Forst, Thomas <br/><br/>
Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.  [electronic resource] 

 -  Diabetes/metabolism research and reviews  Oct 2014 
 - 582-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-7560 
<br/><br/><label>Standard No.: </label>10.1002/dmrr.2525  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Blood Glucose--metabolism<br/>Cardiovascular Diseases--epidemiology<br/>Diabetes Mellitus, Type 2--complications<br/>Drug Therapy, Combination<br/>Female<br/>Glucagon--blood<br/>Glucagon-Like Peptide 1--blood<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--blood<br/>Islets of Langerhans--drug effects<br/>Linagliptin<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--blood<br/>Postprandial Period--physiology<br/>Proinsulin--blood<br/>Purines--pharmacology<br/>Quinazolines--pharmacology<br/>Risk Factors<br/>Sulfonylurea Compounds--pharmacology